Page last updated: 2024-09-05

bifeprunox and apomorphine

bifeprunox has been researched along with apomorphine in 2 studies

Compound Research Comparison

Studies
(bifeprunox)
Trials
(bifeprunox)
Recent Studies (post-2010)
(bifeprunox)
Studies
(apomorphine)
Trials
(apomorphine)
Recent Studies (post-2010) (apomorphine)
301129,205287780

Protein Interaction Comparison

ProteinTaxonomybifeprunox (IC50)apomorphine (IC50)
Tryptophan 5-hydroxylase 1Rattus norvegicus (Norway rat)0.22
D(2) dopamine receptorHomo sapiens (human)0.0146
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)7.75
DRattus norvegicus (Norway rat)0.4744
D(3) dopamine receptorRattus norvegicus (Norway rat)0.1432
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.063
D(2) dopamine receptorBos taurus (cattle)0.3385
D(1A) dopamine receptorHomo sapiens (human)0.025
D(4) dopamine receptorHomo sapiens (human)0.025
D(1B) dopamine receptorHomo sapiens (human)0.025
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)7.75
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(4) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(3) dopamine receptorHomo sapiens (human)0.025
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)7.75
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0813
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.205
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)1.35
DBos taurus (cattle)0.3385

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pettersson, F; Pontén, H; Sonesson, C; Waters, N; Waters, S1
Arnt, J; Dahan, L; Haddjeri, N; Hertel, P; Husum, H; Mnie-Filali, O1

Other Studies

2 other study(ies) available for bifeprunox and apomorphine

ArticleYear
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
    Journal of medicinal chemistry, 2010, Mar-25, Volume: 53, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Cell Line; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Ligands; Male; Models, Chemical; Molecular Structure; Motor Activity; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2

2010
Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Apomorphine; Aripiprazole; Benzoxazoles; Dopamine; Dopamine D2 Receptor Antagonists; Electroshock; Haloperidol; Male; Neurons; Piperazines; Pyridines; Quinolones; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Ultrasonics; Ventral Tegmental Area; Vocalization, Animal

2009